Dr Andrew Roddam is a life sciences executive and internationally recognized epidemiologist with over 25 years’ experience spanning academia, pharmaceuticals, biotechnology, and public health.
He is Chief Business Development Officer at EveryONE Medicines, leading the adoption of precision medicine capabilities from genetic discovery to patient monitoring. Previously, he was CEO of Our Future Health, the UK’s largest health research programme in partnership with the NHS, creating one of the world’s largest prospective cohorts and genetic resources.
An Oxford-trained statistician, Andrew has published over 100 scientific papers and is a regular keynote speaker. He serves as Chair of SNOMED International, where he has been a board director since 2020, and advises multiple organizations on data-driven healthcare innovation.
